Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Vascular access training for REBOA placement: a feasibility study in a live tissue-simulator hybrid porcine model.

Borger van der Burg BLS, Hörer TM, Eefting D, van Dongen TTCF, Hamming JF, DuBose JJ, Bowyer M, Hoencamp R.

J R Army Med Corps. 2019 Jun;165(3):147-151. doi: 10.1136/jramc-2018-000972. Epub 2018 Sep 17.

PMID:
30228195
2.

Supervised preoperative forearm exercise to increase blood vessel diameter in patients requiring an arteriovenous access for hemodialysis: rationale and design of the PINCH trial.

Wilschut ED, Rotmans JI, Bos EJ, van Zoest D, Eefting D, Hamming JF, van der Bogt KEA.

J Vasc Access. 2018 Jan;19(1):84-88. doi: 10.5301/jva.5000826.

PMID:
29148008
3.

Outcomes after foot surgery in people with a diabetic foot ulcer and a 12-month follow-up.

Lenselink E, Holloway S, Eefting D.

J Wound Care. 2017 May 2;26(5):218-227. doi: 10.12968/jowc.2017.26.5.218.

PMID:
28475445
4.

Aortic Aneurysm Rupture After Urokinase Treatment for Acute Limb Ischemia in Two Patients After EVAR.

Sudiono DR, Hoencamp R, Ottevanger J, Eefting D, van der Linden E.

Cardiovasc Intervent Radiol. 2017 Oct;40(10):1641-1644. doi: 10.1007/s00270-017-1671-8. Epub 2017 May 3.

PMID:
28470393
5.

Improvement of radiocephalic fistula maturation: rationale and design of the Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation (LIPMAT) study - a randomized controlled trial.

Voorzaat BM, van Schaik J, van der Bogt KE, Vogt L, Huisman L, Gabreëls BA, van der Meer IM, van Eps RG, Eefting D, Weijmer MC, Groeneveld HO, van Nieuwenhuizen RC, Boom H, Verburgh CA, van der Putten K, Rotmans JI.

J Vasc Access. 2017 Mar 6;18(Suppl. 1):114-117. doi: 10.5301/jva.5000673. Epub 2017 Mar 5.

PMID:
28297049
6.

Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms.

van Sterkenburg SM, Heyligers JM, van Bladel M, Verhagen HJ, Eefting D, van Sambeek MR, Zeebregts CJ, Reijnen MM; Dutch IBE Collaboration.

J Vasc Surg. 2016 Jun;63(6):1451-7. doi: 10.1016/j.jvs.2016.01.021.

7.

Testicular Embolism After Endovascular Aneurysm Repair: A Rare Complication of Endovascular Repair of Abdominal Aortic Aneurysms.

Vervoort M, Hoencamp R, Eefting D.

Cardiovasc Intervent Radiol. 2015 Dec;38(6):1674-5. doi: 10.1007/s00270-015-1153-9. Epub 2015 Jun 24. No abstract available.

PMID:
26104136
8.

Thromboembolic complications after Zenith® Low Profile Endovascular Graft for infrarenal abdominal aneurysms.

Urlings TA, de Vries AC, de Mol van Otterloo JC, Eefting D, van der Linden E.

Cardiovasc Intervent Radiol. 2015 Jun;38(3):600-5. doi: 10.1007/s00270-014-0972-4. Epub 2014 Aug 22.

PMID:
25145923
9.

Differences in mortality, risk factors, and complications after open and endovascular repair of ruptured abdominal aortic aneurysms.

von Meijenfeldt GC, Ultee KH, Eefting D, Hoeks SE, ten Raa S, Rouwet EV, Hendriks JM, Verhagen HJ, Bastos Goncalves FM.

Eur J Vasc Endovasc Surg. 2014 May;47(5):479-86. doi: 10.1016/j.ejvs.2014.01.016. Epub 2014 Feb 20.

10.

Endovascular salvage of a false aneurysm of the posterior tibial artery caused by a stab from a stingray.

van Helden EJ, Eefting D, Florie J, Verhagen HJ, Moelker A.

Cardiovasc Intervent Radiol. 2015 Apr;38(2):498-500. doi: 10.1007/s00270-013-0817-6. Epub 2013 Dec 19. No abstract available.

PMID:
24352862
11.

Ruptured AAA: state of the art management.

Eefting D, Ultee KH, Von Meijenfeldt GC, Hoeks SE, ten Raa S, Hendriks JM, Bastos Goncalves F, Verhagen HJ.

J Cardiovasc Surg (Torino). 2013 Feb;54(1 Suppl 1):47-53. Review.

PMID:
23443589
12.

A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.

Eefting D, Seghers L, Grimbergen JM, de Vries MR, de Boer HC, Lardenoye JW, Jukema JW, van Bockel JH, Quax PH.

Cardiovasc Res. 2010 Nov 1;88(2):367-75. doi: 10.1093/cvr/cvq203. Epub 2010 Jun 17.

PMID:
20562095
13.
14.

Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice.

Eefting D, Bot I, de Vries MR, Schepers A, van Bockel JH, Van Berkel TJ, Biessen EA, Quax PH.

J Vasc Surg. 2009 Jul;50(1):152-60. doi: 10.1016/j.jvs.2009.03.027.

15.

Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.

Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovée JV, Hogendoorn PC; EuroBoNeT consortium.

Am J Surg Pathol. 2009 Jan;33(1):50-7. doi: 10.1097/PAS.0b013e31817eec2b.

PMID:
18852676
16.

Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA.

Eefting D, Grimbergen JM, de Vries MR, van Weel V, Kaijzel EL, Que I, Moon RT, Löwik CW, van Bockel JH, Quax PH.

Hum Gene Ther. 2007 Sep;18(9):861-9.

PMID:
17850190
17.

Natural killer cells and CD4+ T-cells modulate collateral artery development.

van Weel V, Toes RE, Seghers L, Deckers MM, de Vries MR, Eilers PH, Sipkens J, Schepers A, Eefting D, van Hinsbergh VW, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2310-8. Epub 2007 Aug 23.

PMID:
17717295
18.
19.

Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.

Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Huizinga TW, Eefting D, Quax PH, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

Genes Immun. 2007 Jan;8(1):44-50. Epub 2006 Nov 23.

PMID:
17122782
20.

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice.

Eefting D, Schepers A, De Vries MR, Pires NM, Grimbergen JM, Lagerweij T, Nagelkerken LM, Monraats PS, Jukema JW, van Bockel JH, Quax PH.

Atherosclerosis. 2007 Aug;193(2):335-42. Epub 2006 Nov 7.

PMID:
17087966
21.

Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation.

van Bezooijen RL, Svensson JP, Eefting D, Visser A, van der Horst G, Karperien M, Quax PH, Vrieling H, Papapoulos SE, ten Dijke P, Löwik CW.

J Bone Miner Res. 2007 Jan;22(1):19-28.

22.

Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems.

Madeddu P, Emanueli C, Spillmann F, Meloni M, Bouby N, Richer C, Alhenc-Gelas F, Van Weel V, Eefting D, Quax PH, Hu Y, Xu Q, Hemdahl AL, van Golde J, Huijberts M, de Lussanet Q, Struijker Boudier H, Couffinhal T, Duplaa C, Chimenti S, Staszewsky L, Latini R, Baumans V, Levy BI.

Vascul Pharmacol. 2006 Nov;45(5):281-301. Epub 2006 Aug 22. Review.

PMID:
17010676
23.

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V, de Vries CJ, Egashira K, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2063-9. Epub 2006 Jul 6.

PMID:
16825596
24.

Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice.

Schepers A, Pires NM, Eefting D, de Vries MR, van Bockel JH, Quax PH.

J Vasc Surg. 2006 Apr;43(4):809-15.

Supplemental Content

Loading ...
Support Center